Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-25T20:21:10.364Z Has data issue: false hasContentIssue false
  • English
  • Français

IMITREX

Published online by Cambridge University Press:  18 September 2015

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Other
Information
Canadian Journal of Neurological Sciences , Volume 24 , Issue 2 , May 1997 , pp. xxxix - xl
Copyright
Copyright © Canadian Neurological Sciences Federation 1997

References

REFERENCES:

1.Product Monograph of IMITREX®, Glaxo Wellcome Inc., 1996.Google Scholar
2.Ryan, R.et al. The efficacy and tolerability of sumatriptan 5, 10 and 20 mg nasal sprays in the acute treatment of repeated attacks of migraine. Presented at the 7th International Headache Congress. Sept. 16–20, 1995. Toronto, Canada.Google Scholar
3.Becker, WJet al. A placebo-controlled, dose-defining study of sumatriptan nasal spray in the acute treatment of migraine. Presented at the 7th International Headache Congress. Sept. 16–20, 1995. Toronto, Canada.Google Scholar